Researchers from the Federal University of Rio de Janeiro await regulatory clearance to begin human testing of an anti-coronavirus serum developed from the plasma of equines. In early tests, the serum presented antibodies up to 150 times more potent than those found in patients infected with Sars-CoV-2. If late-stage trials go ahead as planned, the serum could reach patients by mid-2021.
“We won’t have more than 60 percent of the population vaccinated before next year, even by the most optimistic forecasts,” says Jerson Silva, one of the project’s researchers. “Ideally, we could use the serum to treat those who have been infected.”
A similar study is underway in the São Paulo-based Butantan Biological Institute, which is also involved in the local production of the Chinese-made CoronaVac vaccine. After five months of research, scientists have administered the serum on hamsters to induce an immune response.
Support this coverage →President Luiz Inácio Lula da Silva issued a provisional decree laying the foundations for Eco…
Finance Minister Fernando Haddad on Wednesday delivered to House Speaker Arthur Lira a bill with…
Brazil's IPCA-15 mid-month inflation measurement posted a 0.21 percent increase in April, following the 0.36…
It is not about denying the environmental problems and challenges Brazil faces — that are…
Shareholders of Brazil’s oil giant Petrobras approved in a Thursday general meeting the payment of…
This week, the world celebrates International Earth Day, a yearly call to action to confront…